Simon Sinclair

635 total citations
17 papers, 513 citations indexed

About

Simon Sinclair is a scholar working on Physiology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Simon Sinclair has authored 17 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 6 papers in Cellular and Molecular Neuroscience and 6 papers in Psychiatry and Mental health. Recurrent topics in Simon Sinclair's work include Migraine and Headache Studies (5 papers), Nerve injury and regeneration (5 papers) and Neurogenesis and neuroplasticity mechanisms (5 papers). Simon Sinclair is often cited by papers focused on Migraine and Headache Studies (5 papers), Nerve injury and regeneration (5 papers) and Neurogenesis and neuroplasticity mechanisms (5 papers). Simon Sinclair collaborates with scholars based in United Kingdom, Belgium and United States. Simon Sinclair's co-authors include Stephen B. Dunnett, James W. Fawcett, David Martín, Eduardo M. Torres, Clive N. Svendsen, Inge De Lepeleire, Anne Van Hecken, Stefanie A. Kane, Marleen Depré and Bart Van der Schueren and has published in prestigious journals such as Journal of Neuroscience, International Journal of Molecular Sciences and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Simon Sinclair

15 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon Sinclair United Kingdom 10 307 153 143 140 120 17 513
C. Triban Italy 13 262 0.9× 93 0.6× 211 1.5× 69 0.5× 136 1.1× 21 613
Prakasham Rumajogee Canada 11 234 0.8× 102 0.7× 187 1.3× 48 0.3× 65 0.5× 15 579
Niklas Koehler Germany 10 171 0.6× 96 0.6× 84 0.6× 30 0.2× 145 1.2× 20 458
Ingela Nilsson Remahl Sweden 8 136 0.4× 37 0.2× 42 0.3× 88 0.6× 92 0.8× 17 301
David P. Bonislawski United States 8 257 0.8× 64 0.4× 283 2.0× 43 0.3× 33 0.3× 8 547
Zhi Hou China 9 123 0.4× 45 0.3× 137 1.0× 124 0.9× 55 0.5× 14 407
Yueh‐Jan Wang Taiwan 14 221 0.7× 86 0.6× 98 0.7× 17 0.1× 85 0.7× 28 485
Juan J. López Costa Argentina 8 150 0.5× 47 0.3× 98 0.7× 40 0.3× 57 0.5× 10 362
P. Cherkas Israel 5 194 0.6× 65 0.4× 95 0.7× 25 0.2× 193 1.6× 5 373
Prateesh Trivedi United Kingdom 6 247 0.8× 39 0.3× 47 0.3× 26 0.2× 250 2.1× 12 434

Countries citing papers authored by Simon Sinclair

Since Specialization
Citations

This map shows the geographic impact of Simon Sinclair's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Sinclair with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Sinclair more than expected).

Fields of papers citing papers by Simon Sinclair

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Sinclair. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Sinclair. The network helps show where Simon Sinclair may publish in the future.

Co-authorship network of co-authors of Simon Sinclair

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Sinclair. A scholar is included among the top collaborators of Simon Sinclair based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Sinclair. Simon Sinclair is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Bruin, Natasja de, Sandra Ciesek, Denisa Bojková, et al.. (2022). Ibuprofen, Flurbiprofen, Etoricoxib or Paracetamol Do Not Influence ACE2 Expression and Activity In Vitro or in Mice and Do Not Exacerbate In-Vitro SARS-CoV-2 Infection. International Journal of Molecular Sciences. 23(3). 1049–1049. 16 indexed citations
2.
Sinclair, Simon. (2020). Making Doctors. 5 indexed citations
3.
Han, Tae Hyung, Rebecca Blanchard, John Palcza, et al.. (2010). Single‐ and Multiple‐Dose Pharmacokinetics and Tolerability of Telcagepant, an Oral Calcitonin Gene‐Related Peptide Receptor Antagonist, in Adults. The Journal of Clinical Pharmacology. 50(12). 1367–1376. 29 indexed citations
4.
Sinclair, Simon, Stefanie A. Kane, Bart Van der Schueren, et al.. (2009). Inhibition of capsaicin‐induced increase in dermal blood flow by the oral CGRP receptor antagonist, telcagepant (MK‐0974). British Journal of Clinical Pharmacology. 69(1). 15–22. 70 indexed citations
5.
Schueren, Bart Van der, Anne Rogiers, F. H. Vanmolkot, et al.. (2008). Calcitonin Gene-Related Peptide8-37 Antagonizes Capsaicin-Induced Vasodilation in the Skin: Evaluation of a Human in Vivo Pharmacodynamic Model. Journal of Pharmacology and Experimental Therapeutics. 325(1). 248–255. 39 indexed citations
6.
Sinclair, Simon, Inge De Lepeleire, Rebecca Blanchard, et al.. (2007). Inhibition of capsaicin-induced increase in dermal microvascular blood flow by the oral CGRP antagonist, MK-0974. Cephalalgia. 27(6). 738–739. 7 indexed citations
7.
Sinclair, Simon, Inge De Lepeleire, Stefanie A. Kane, et al.. (2007). MK-0974, a novel oral CGRP antagonist, exhibits similar pharmacokinetics during and between migraine attacks. Headache The Journal of Head and Face Pain. 47(5). 811–812. 7 indexed citations
8.
Schueren, Bart Van der, Jan de Hoon, Yingling Xu, et al.. (2007). MK-0974, an oral CGRP antagonist, inhibits capsaicin-induced vasodilation in the human skin. Basic & Clinical Pharmacology & Toxicology. 101. 33–34. 2 indexed citations
9.
Schueren, Bart Van der, Jan de Hoon, F. H. Vanmolkot, et al.. (2007). Reproducibility of the capsaicin‐induced dermal blood flow response as assessed by laser Doppler perfusion imaging. British Journal of Clinical Pharmacology. 64(5). 580–590. 53 indexed citations
10.
Sinclair, Simon, Kun Xiao, John Palcza, et al.. (2007). MK-0974 Oral CGRP Antagonist Inhibits Capsaicin-induced Increase in Dermal Microvascular Blood Flow. 47(5). 811. 7 indexed citations
11.
Schueren, Bart Van der, et al.. (2006). Capsaicin-induced vasodilation in the human skin as a pharmacodynamic model to test CGRP antagonists in vivo. British Journal of Clinical Pharmacology. 62(6). 733–734.
12.
Zietlow, Rike, Simon Sinclair, Christof J. Schwiening, Stephen B. Dunnett, & James W. Fawcett. (2002). The Release of Excitatory Amino Acids, Dopamine, and Potassium following Transplantation of Embryonic Mesencephalic Dopaminergic Grafts to the Rat Striatum, and Their Effects on Dopaminergic Neuronal Survival In Vitro. Cell Transplantation. 11(7). 637–652. 10 indexed citations
13.
Sinclair, Simon, James W. Fawcett, & Stephen B. Dunnett. (1999). Delayed implantation of nigral grafts improves survival of dopamine neurones and rate of functional recovery. Neuroreport. 10(6). 1263–1267. 23 indexed citations
14.
Sinclair, Simon, James W. Fawcett, & Stephen B. Dunnett. (1999). Dopamine cells in nigral grafts differentiate prior to implantation. European Journal of Neuroscience. 11(12). 4341–4348. 52 indexed citations
16.
Sinclair, Simon, Clive N. Svendsen, Eduardo M. Torres, et al.. (1996). GDNF enhances dopaminergic cell survival and fibre outgrowth in embryonic nigral grafts. Neuroreport. 7(15). 2547–2552. 108 indexed citations
17.
Sethi, Amarjit Singh & Simon Sinclair. (1968). Developmental pharmacology. The Indian Journal of Pediatrics. 35(8). 403–412.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026